Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Immunologic mechanisms in multiple sclerosis. Exacerbation by type A hepatitis and skin test antigens.

Owen RL, Dau PC, Johnson KP, Spitler LE.

JAMA. 1980 Nov 21;244(20):2307-9.

PMID:
7431554
2.

Multiple sclerosis: an overview, with some observations on the spinal fluid protein.

Darnell D, Abrams BM, Moroney J.

J Am Osteopath Assoc. 1974 Feb;73(6):450-4. No abstract available.

PMID:
4360489
3.

[IgM immunoglobulin in cerebrospinal fluid in cases of multiple sclerosis (preliminary report)].

Wajgt A.

Neurol Neurochir Pol. 1975 May-Jun;9(3):327-9. Polish.

PMID:
1153062
4.

Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosis.

Coyle PK, Brooks BR, Hirsch RL, Cohen SR, O'Donnell P, Johnson RT, Wolinsky JS.

Lancet. 1980 Aug 2;2(8188):229-32.

PMID:
6105395
5.

Preparation of antisera directed against the idiotype(s) of immunoglobulin G from the cerebrospinal fluid of patients with multiple sclerosis.

Nagelkerken LM, Aalberse RC, van Walbeek HK, Out TA.

J Immunol. 1980 Jul;125(1):384-9. No abstract available.

PMID:
7381204
6.

Plasmapheresis in multiple sclerosis: preliminary study.

Weiner HL, Dawson DM.

Neurology. 1980 Oct;30(10):1029-33.

PMID:
7191492
8.
9.

Immunoglobulin abnormalities in spinal fluid in multiple sclerosis.

Link H, Möller E, Muller R, Norrby E, Olsson JE, Stendahl L, Tibbling G.

Acta Neurol Scand Suppl. 1977;63:173-91. No abstract available.

PMID:
265665
10.

Plasmapheresis in multiple sclerosis: preliminary findings.

Dau PC, Petajan JH, Johnson KP, Panitch HS, Bornstein MB.

Neurology. 1980 Oct;30(10):1023-8.

PMID:
6448360
12.

[Local cerebrospinal fluid IgG production in multiple sclerosis].

Schipper H.

Schriftenr Neurol. 1989;30:1-91. Review. German. No abstract available.

PMID:
2678429
13.
14.

Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.

Stendahl-Brodin L, Link H, Möller E, Norrby E.

Acta Neurol Scand. 1979 Jun;59(6):297-308.

PMID:
90443
15.

Skin-fixing antibodies and neurological disorders.

Ansari KA.

Trans Am Neurol Assoc. 1970;95:198-200. No abstract available.

PMID:
5514367
16.

[Cerebrospinal fluid in multiple sclerosis. Its diagnostic value under immunologic aspects].

Delank HW.

Fortschr Neurol Psychiatr Grenzgeb. 1972 Aug;40(8):440-53. German. No abstract available.

PMID:
4484562
17.

Lymphotoxic activity in multiple sclerosis serum.

Van den Noort S, Stjernholm RL.

Neurology. 1971 Aug;21(8):783-93. No abstract available.

PMID:
5106294
18.

Antibodies against different viral antigens in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

Salmi A, Panelius M, Vainionpää R.

Acta Neurol Scand. 1974;50(2):183-93. No abstract available.

PMID:
4209144
19.

Multiple sclerosis and elevation of cerebrospinal fluid vaccinia virus antibody.

Thompson JA, Bray PF, Glasgow LA.

Neurology. 1975 Jan;25(1):94-6.

PMID:
1167412
20.

Clinical significance of immunologic and immunogenetic evaluation in multiple sclerosis.

Jozefczyk PB, Kelly RH, Rabin BS.

Immunol Commun. 1984;13(4):371-9.

PMID:
6434406

Supplemental Content

Support Center